The dysmenorrhea market size is expected to grow at a compound annual growth rate (CAGR) of 5.7% during the forecast period of 2024-2032, driven by the rising incidence of endometriosis and uterine fibroids due to hormonal imbalances in women across major markets. Dysmenorrhea, or painful menstruation, affects a significant portion of women worldwi